Literature DB >> 29417612

Diabetes stigma is associated with negative treatment appraisals among adults with insulin-treated Type 2 diabetes: results from the second Diabetes MILES - Australia (MILES-2) survey.

E Holmes-Truscott1,2, J L Browne1,2, A D Ventura1,2, F Pouwer3, J Speight1,2,4.   

Abstract

AIM: To explore factors associated with negative insulin appraisals among adults with Type 2 diabetes, including perceived and experienced diabetes stigma.
METHODS: The second Diabetes MILES - Australia study (MILES-2) is a national survey of adults with diabetes, focused on behavioural and psychosocial issues. Subgroup analyses were conducted on the responses of 456 adults with insulin-treated Type 2 diabetes (38% women; mean ± sd age: 61.2 ± 8.8 years; diabetes duration: 14.5 ± 7.5 years; years using insulin: 6.4 ± 5.5). Participants completed validated measures of perceived and experienced diabetes stigma (Type 2 Diabetes Stigma Assessment Scale), insulin appraisals [Insulin Treatment Appraisal Scale (ITAS)] and known correlates of insulin appraisals: diabetes-specific distress (Problem Areas In Diabetes scale) and diabetes-specific self-efficacy (Confidence in Diabetes Self-care scale). A multiple linear regression was conducted (N = 279) to determine the contribution of those variables found to be associated with ITAS Negative scores.
RESULTS: Univariable analyses revealed negative insulin appraisals were associated with demographic and self-care characteristics (age, employment status, BMI, years using insulin, injections per day), self-efficacy, diabetes-specific distress and diabetes stigma (all P < 0.01). Number of injections per day [regression coefficient [95% confidence interval]: 0.74 [0.08, 1.40]; P = 0.028], self-efficacy [-0.12 [-0.19, -0.06]; P < 0.001] and diabetes stigma [0.39 (0.31, 0.46); P < 0.001) significantly and independently contributed to the final multivariable model, explaining 58% of the variance in ITAS Negative scores. The independent contribution of diabetes-specific distress was suppressed following the inclusion of diabetes stigma.
CONCLUSIONS: This study represents the first step in understanding the relationship between perceived and experienced diabetes stigma and negative insulin appraisals, and provides quantitative evidence for the strong, independent relationship between these two important constructs.
© 2018 Diabetes UK.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29417612     DOI: 10.1111/dme.13598

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  7 in total

1.  Improving Transition to Insulin Through Clinical Conversations.

Authors:  Jana L Wardian
Journal:  Clin Diabetes       Date:  2020-07

2.  Weight Stigma and Diabetes Stigma: Implications for Weight-Related Health Behaviors in Adults With Type 2 Diabetes.

Authors:  Rebecca M Puhl; Mary S Himmelstein; Jane Speight
Journal:  Clin Diabetes       Date:  2022-01

3.  Impact of pharmacist insulin injection re-education on glycemic control among type II diabetic patients in primary health clinics.

Authors:  Selvakumari Selvadurai; Kit Yee Cheah; Min Wei Ching; Hanisah Kamaruddin; Xiao You Lee; Radhiatul Mardhiyah Ngajidin; Xian Hui Lee; Lina Mariana Mohd Ali
Journal:  Saudi Pharm J       Date:  2021-04-30       Impact factor: 4.330

4.  Latinos' Conceptualization of Depression, Diabetes, and Mental Health-Related Stigma.

Authors:  Micki Washburn; Kathryne Brewer; Robin Gearing; Roberta Leal; Miao Yu; Luis Torres
Journal:  J Racial Ethn Health Disparities       Date:  2021-09-10

5.  DiabetesSistersVoices: Virtual Patient Community to Identify Research Priorities for Women Living With Diabetes.

Authors:  Peijin Han; Wanda Nicholson; Anna Norton; Karen Graffeo; Richard Singerman; Steven King; Aditi Sundaresan; Wendy Bennett
Journal:  J Med Internet Res       Date:  2019-05-10       Impact factor: 5.428

6.  A Cross-Sectional Analysis of the Stigma Surrounding Type 2 Diabetes in Colombia.

Authors:  Victor Pedrero; Jorge Manzi; Luz Marina Alonso
Journal:  Int J Environ Res Public Health       Date:  2021-12-01       Impact factor: 3.390

7.  The Tongue is Mightier than the Sword.

Authors:  S V Madhu; Nishant Raizada
Journal:  Indian J Endocrinol Metab       Date:  2021 Sep-Oct
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.